Quince Therapeutics | ARS:年度報告
04/24 16:15 (美東)
Quince Therapeutics | DEFA14A:其他
04/24 16:11 (美東)
Quince Therapeutics | DEF 14A:股東委託書決議
04/24 16:07 (美東)
Quince Therapeutics | PRE 14A:並購重組委托聲明
04/11 16:41 (美東)
Quince Therapeutics | S-8:員工福利計劃證券登記
04/01 17:23 (美東)
Quince Therapeutics | 10-K:年度報表
04/01 16:54 (美東)
Quince Therapeutics | 4:持股變動聲明-董事 Patni Rajiv
02/15 18:18 (美東)
Quince Therapeutics | 3:首次持股聲明-董事 Patni Rajiv
02/15 18:13 (美東)
Quince Therapeutics | 8-K:重大事件
02/15 16:03 (美東)
Quince Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(7.5%),Tang Capital Management, LLC(7.5%)等
02/14 16:04 (美東)
Quince Therapeutics | SC 13G:超過5%持股股東披露文件-Sofinnova Capital VIII (“SC VIII”)(5.1%),Sofinnova Partners SAS, a French corporation (“SP SAS”)(5.1%)等
02/12 09:04 (美東)
Quince Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-BML Investment Partners, L.P.(0.0%),Braden M Leonard(0.0%)
02/07 10:51 (美東)
Quince Therapeutics | 4:持股變動聲明-高管 Ryan Charles S.
02/02 18:06 (美東)
Quince Therapeutics | 4:持股變動聲明-高管 Hannah Brendan
02/02 17:56 (美東)
Quince Therapeutics | 4:持股變動聲明-高管 Thye Dirk
02/02 17:52 (美東)
Quince Therapeutics | 8-K:重大事件
01/29 16:07 (美東)
Quince Therapeutics | 4:持股變動聲明-高管 Thye Dirk
01/17 00:00 (美東)
Quince Therapeutics | 8-K/A:重大事件(修正)
01/05 00:00 (美東)
Quince Therapeutics | 8-K:重大事件
01/03 00:00 (美東)
Quince Therapeutics | 8-K:重大事件
2023/12/22 16:08 (美東)
暫無數據
暫無數據